George Ingle Finch, 1888-1970

George Edgar Septimus Ward, 1888-1969.

George I. Finch and his pioneering use of oxygen for climbing at extreme altitudes.

George Ingle Finch (1888-1970) was the first person to prove the great value of supplementary oxygen for climbing at extreme altitudes. He did this during the 1922 Everest expedition when he and his companion, Geoffrey Bruce, reached an altitude of 8,320 m, higher than any human had climbed before. Finch was well qualified to develop the oxygen equipment because he was an eminent physical chemi...

Stanhope Bayne-Jones (1888-1970). Medical Dean, Military Hero, Microbiologist and Epidemiologist, and Medical Historian.

Stanlhope Bayne-Jones (B-J, as he soon came to be known) led a life which included at least fotur or five careers. Any one of them would have satisfied most men. He was born in New Orleans, Louisiana, and unfortunately was orphaned at an early age. He always took pride in the fact that he had been descended from distinguislhed medical forebears, one of whom was Dr. Joseph Jones, a prominent Lou...

Op-brai130100 1868..1888

Functional magnetic resonance imaging has demonstrated reorganization of memory encoding networks within the temporal lobe in temporal lobe epilepsy, but little is known of the extra-temporal networks in these patients. We investigated the temporal and extra-temporal reorganization of memory encoding networks in refractory temporal lobe epilepsy and the neural correlates of successful subsequen...

Dmd053595 1888..1895

Olmesartan medoxomil (OM) is a prodrug-type angiotensin II type 1 receptor blocker (ARB). We recently identified carboxymethylenebutenolidase homolog (CMBL) as the responsible enzyme for OM bioactivation in humans. In the present study, we compared the bioactivating properties of OM with those of other prodrug-type ARBs, candesartan cilexetil (CC) and azilsartan medoxomil (AM), by focusing on i...